Guo Tian
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis 10
- Liver Disease and Transplantation 4
- Epidemiology top 10%
- Liver Disease Diagnosis and Treatment 10
- Neuroendocrine Tumor Research Advances 4
- Biotechnology top 10%
- Microbial Inactivation Methods 11
-
- Pancreatic and Hepatic Oncology Research 9
-
- Ultrasound and Hyperthermia Applications 6
-
- Pancreatitis Pathology and Treatment 5
- Cited by
- HepatologyEpidemiologyBiotechnology
- Journals
- SHILAP Revista de lepidopterología (1 paper)PLoS ONE (1 paper)Hepatology (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Guo Tian
51 papers receiving 778 citations
Peers
Comparison fields: 5 of 88
- Hepatology 275
- Epidemiology 346
- Biotechnology 66
- Oncology 147
- Cancer Research 67
Countries citing papers authored by Guo Tian
This map shows the geographic impact of Guo Tian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guo Tian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guo Tian more than expected).
Fields of papers citing papers by Guo Tian
This network shows the impact of papers produced by Guo Tian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guo Tian. The network helps show where Guo Tian may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Guo Tian, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2022 | 5 | |
| 5 | 2021 | 20 | |
| 6 | 2020 | 11 | |
| 7 | 2020 | 65 | |
| 8 | 2020 | 9 | |
| 9 | 2020 | 1 | |
| 10 | 2020 | 9 | |
| 11 | 2020 | 17 | |
| 12 | 2018 | 41 | |
| 13 | 2018 | 1 | |
| 14 | 2018 | 3 | |
| 15 | 2018 | 5 | |
| 16 | 2018 | 17 | |
| 17 | 2017 | 2 | |
| 18 | 2016 | 18 | |
| 19 | 2016 | 19 | |
| 20 | 2016 | 46 |
About Guo Tian
Guo Tian is a scholar working on Hepatology, Biotechnology and Epidemiology, having authored 52 papers that have together received 789 indexed citations. Recurring topics across this work include Microbial Inactivation Methods (11 papers), Hepatocellular Carcinoma Treatment and Prognosis (10 papers), Liver Disease Diagnosis and Treatment (10 papers), Pancreatic and Hepatic Oncology Research (9 papers), Ultrasound and Hyperthermia Applications (6 papers), Pancreatitis Pathology and Treatment (5 papers), Liver Disease and Transplantation (4 papers) and Neuroendocrine Tumor Research Advances (4 papers). The work is most often cited by research in Hepatology (275 citations), Epidemiology (346 citations) and Biotechnology (66 citations). Guo Tian has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Tianan Jiang, Qiyu Zhao, Lanjuan Li, De-Xing Kong, Shigui Yang, Fen Chen, Fen Chen, Cheng Ding, Xiaofang Fu and Jie Wu. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.